Patents by Inventor Harini Shandilya

Harini Shandilya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11214823
    Abstract: The present invention relates to sample-to-answer systems, devices, cartridges, and method of using the same for detecting the presence of microorganisms in a sample, such as bacteria.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: January 4, 2022
    Assignee: Canon U.S.A., Inc.
    Inventors: Abhijit Dohale, Arvind Virmani, Brian Scrivens, Christopher Sneeder, Denis Alias, George Maltezos, Hanyoup Kim, Harini Shandilya, Hongye Liang, Jason Zsak, Johnathan Stuart Coursey, Kenton C. Hasson, Melissa Gosse, Shulin Zeng, Yasuyuki Numajiri, Makoto Ogusu, Yoichi Murakami, Kunihiro Sakai
  • Publication number: 20170327867
    Abstract: The present invention relates to sample-to-answer systems, devices, cartridges, and method of using the same for detecting the presence of microorganisms in a sample, such as bacteria.
    Type: Application
    Filed: December 22, 2016
    Publication date: November 16, 2017
    Applicant: Canon U.S. Life Sciences, Inc.
    Inventors: Abhijit Dohale, Arvind Virmani, Brian Scrivens, Christopher Sneeder, Denis Alias, George Maltezos, Hanyoup Kim, Harini Shandilya, Hongye Liang, Jason Zsak, Johnathan Stuart Coursey, Kenton C. Hasson, Melissa Gosse, Shulin Zeng, Yasuyuki Numajiri, Makoto Ogusu, Yoichi Murakami, Kunihiro Sakai
  • Publication number: 20160108381
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may possess both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: October 5, 2015
    Publication date: April 21, 2016
    Inventors: Jun LEE, Gary Gerard, Harini Shandilya, Katherine Griffiths, Moreland Gibbs, Peter Bergquist, Robert Potter
  • Publication number: 20120094332
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may possess both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: December 30, 2010
    Publication date: April 19, 2012
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Jun Lee, Gary Gerard, Harini Shandilya, Katherine R. Griffiths, Moreland D. Gibbs, Peter L. Bergquist, Robert Jason Potter
  • Patent number: 7560261
    Abstract: The present invention relates to isolated nucleic acid sequences encoding CEL II endonuclease and vectors and host cells for producing a protein encoded thereby.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: July 14, 2009
    Assignee: Transgenomic, Inc.
    Inventors: Harini Shandilya, Gary F. Gerard, Peter Qiu
  • Publication number: 20070231904
    Abstract: The present invention relates to isolated nucleic acid sequences encoding CEL II endonuclease and vectors and host cells for producing a protein encoded thereby.
    Type: Application
    Filed: May 18, 2005
    Publication date: October 4, 2007
    Inventors: Harini Shandilya, Gary Gerard, Peter Qiu
  • Publication number: 20070020622
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may posses both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: September 16, 2002
    Publication date: January 25, 2007
    Inventors: Jun Lee, Gary Gerard, Harini Shandilya, Katherine Griffiths, Moreland Gibbs, Peter Bergquist, Robert Potter
  • Publication number: 20060286598
    Abstract: The present invention relates to the isolation and characterization of CEL I and CEL II endonuclease proteins. Methods and kits for identifying mismatches in double-stranded DNA are also provided.
    Type: Application
    Filed: August 22, 2006
    Publication date: December 21, 2006
    Inventors: Gary Gerard, Harini Shandilya, Peter Qiu, James D'Alessio
  • Patent number: 7129075
    Abstract: The present invention relates to the isolation and characterization of CEL I and CEL II endonuclease proteins. Methods and kits for identifying mismatches in double-stranded DNA are also provided.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: October 31, 2006
    Assignee: Transgenomic, Inc.
    Inventors: Gary F. Gerard, Harini Shandilya, Peter Qiu, James M. D'Alessio
  • Publication number: 20040166510
    Abstract: The present invention relates to the isolation and characterization of CEL I and CEL II endonuclease proteins. Methods and kits for identifying mismatches in double-stranded DNA are also provided.
    Type: Application
    Filed: October 17, 2003
    Publication date: August 26, 2004
    Inventors: Gary F. Gerard, Harini Shandilya, Peter Qiu, James M. D'Alessio
  • Patent number: 5965399
    Abstract: The invention relates to the cloning of a gene encoding rat liver ribonuclease inhibitor (RI), and its expression in a cellular host. In addition, the invention relates to the successful cloning of a gene encoding porcine liver RI, and its expression in a cellular host.
    Type: Grant
    Filed: February 4, 1997
    Date of Patent: October 12, 1999
    Assignee: Life Technologies, Inc.
    Inventors: Deb K. Chatterjee, Harini Shandilya
  • Patent number: 5932440
    Abstract: The invention relates to the cloning of a gene encoding rat liver RI, and its expression in a cellular host. In addition, the invention relates to the successful cloning of a gene encoding porcine liver RI, and its expression in a cellular host. The invention also relates to the cloning and expression of human liver RI, and the cloning and expression of chimeric mammalian RIs, particularly chimeric porcine/human liver RIs, which may be thermostable. The invention also relates to methods and kits for use in producing nucleic acid molecules and polypeptides using the RIs of the invention, and to nucleic acid molecules and polypeptides produced using these methods and kits.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: August 3, 1999
    Assignee: Life Technologies, Inc.
    Inventors: Deb K. Chatterjee, Harini Shandilya